A Look at EAA AirVenture Oshkosh 2017

OSHKOSH, Wisconsin (PRWEB) July 18, 2017

Wittman Regional Airport will soon become the world's busiest airport at least for one week. From July 24-30, more than 10,000 aircraft and a half a million flight enthusiasts will descend for the 65th annual Experimental Aircraft Association fly-in convention, EAA AirVenture Oshkosh 2017. Visitors from 80 countries, many of whom fly in, will take in daily air shows, including two by the U.S. Navy's Blue Angels and a historical reenactment of the WWII Doolittle Raid featuring up to 16 vintage B-25 bombers.

Headlining the week's events will be a July 28 reunion of eight of the 15 living Apollo Mission astronauts, in celebration of the 50th anniversary of NASA's seminal moon exploration program. Commercial space travel will also be highlighted, with Jeff Bezos' Blue Origin passenger rocket (and crew capsule) on display.

In addition, EAA AirVenture Oshkosh 2017 will feature one of the world's largest displays of experimental, vintage and military aircraft (including the only two B-29s still flying); special programs for female flight enthusiasts (WomenVenture); a camp for teen girls interested in aviation; children's programming (KidVenture); myriad stunt and aerobatics performances; flight experiences; a nightly "fly-in" theater with films on a five-story tall screen; and access to the EAA Aviation Museum.

Daily B-roll 
Daily highlights will be available to media on the FTP site http://media.eaa.org using the ID "eaamedia" and password "airventure2012" for photos and video.

About EAA AirVenture Oshkosh
For more information on EAA AirVenture Oshkosh 2017, visit http://www.eaa.org/airventure. Immediate news is available at http://www.twitter.com/EAA.

Media Contacts:
Dick Knapinski, EAA Director of Communications
Phone: (920) 426-6523
Email: dknapinski(at)eaa(dot)org

Andy Larsen, B+L Director of PR
Phone: (414) 271-0101, ext. 119
Email: alarsen(at)boelterlincoln(dot)com

Read the full story at http://www.prweb.com/releases/2017/07/prweb14516647.htm

You May Also Be Interested In

• Agenus Reports 72% of Patients with Locally Advanced dMMR Colon Cancer Had No Cancer Remaining at Surgery Following Six Weeks of BOT+BAL in Phase 2 NEOASIS Study at ESMO 2026
• SI vs. AI: Super Intelligence Anomaly Outbreaks Trump’d by Clinton Legacy Tech (Veterans First for America)
• New data on Lilly's investigational treatment olomorasib at ESMO 2026 show durable first-line activity in KRAS G12C-mutant non-small cell lung cancer